The NNI has just released its 2014 draft Strategic Plan for public comment. Aside from the opportunity to submit comments, becoming familiar with the plan offers a number of benefits to nanotech ventures. One is that it provides a useful overview of the agencies involved, which can make it easier to identify potential soures of government funding. It is easy to get lost in government alphabet soup, but this document explains the roles of various agencies and shows their areas of focus. For example, the report provides a link to “Nanotech Signature Initiatives” (NSI’s), which are a high priority from the government’s perspective for development. These areas include nanoscale solar energy collection and conversion, sustainable nanomanufacturing, and nanoelectronics. More info about NSI’s is found here. Another benefit of reviewing the plan is that it provides case studies of successful commercialization of nanotechnology. Insights from a number of different studies is provided in appendices near the end of the plan.
Related Insights
09 May 2024
Events
The Changing Hospital Landscape
Foley partner Larry Vernaglia, co-chair of the firm’s Providers of Health Care Services Area of Focus, is moderating a panel at the 2024 Convergence Forum titled “The Changing Hospital Landscape.”
23 April 2024
Article
U.S. Supreme Court Rules That “Pure Omissions” Are Not Actionable Under Rule 10b-5
On April 12, 2024, the United States Supreme Court delivered an important decision on the issue of whether a failure to make disclosure required under Item 303 of Regulation S-K can support a Rule 10b-5 claim, even in the absence of an otherwise-misleading statement.
23 April 2024
PharmaPatents
USPTO Issues Updated Guidance on Obviousness
For the first time in nearly 15 years, the U.S. Patent and Trademark Office has issued “Updated Guidance for Making a Proper Determination of Obviousness” under the U.S. Supreme Court’s ruling in KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398 (2007).